MedPath

BRAINCELLS INC

BRAINCELLS INC logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-03-08
Last Posted Date
2012-05-09
Lead Sponsor
BrainCells Inc.
Target Recruit Count
30
Registration Number
NCT01548703
Locations
πŸ‡³πŸ‡±

PRA International, Zuidlaren, Netherlands

A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: BCI-1038, BCI-1206 & BCI-1283
First Posted Date
2012-03-07
Last Posted Date
2012-03-07
Lead Sponsor
BrainCells Inc.
Target Recruit Count
31
Registration Number
NCT01546051
Locations
πŸ‡³πŸ‡±

PRA International, Zuidlaren, Netherlands

Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety

Phase 2
Completed
Conditions
Major Depressive Disorder
Anxiety
Interventions
First Posted Date
2008-02-22
Last Posted Date
2011-10-24
Lead Sponsor
BrainCells Inc.
Target Recruit Count
115
Registration Number
NCT00621270
Locations
πŸ‡¨πŸ‡¦

Dr. D. McIntosh & Dr. K. Kjernisted Clinical Research Inc., Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

Sanjay Siddhartha, MD, Miramichi, New Brunswick, Canada

πŸ‡¨πŸ‡¦

Okanagan Clinical Trials, Kelowna, British Columbia, Canada

and more 13 locations
Β© Copyright 2025. All Rights Reserved by MedPath